Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, Y.
Right arrow Articles by Tokino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, Y.
Right arrow Articles by Tokino, T.
[Cancer Research 63, 8145-8152, December 1, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Identification of the Interleukin 4 Receptor {alpha} Gene as a Direct Target for p73

Yasushi Sasaki12, Hiroaki Mita12, Minoru Toyota12, Setsuko Ishida1, Ichiro Morimoto12, Toshiharu Yamashita1, Toshihiro Tanaka3, Kohzoh Imai2, Yusuke Nakamura3 and Takashi Tokino1

1 Department of Molecular Biology, Cancer Research Institute, and
2 First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, and
3 Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

p73 has a high degree of structural homology to p53 and can activate transcription of p53-responsive genes. However, analysis of p73-deficient mice revealed a marked divergence in the physiological activities of p53 family genes and distinguishes p73 from p53. Mice deficient for p73 exhibit profound defects, including hippocampal dysgenesis, chronic infection, and inflammation, as well as abnormalities in pheromone sensory pathways. p73 plays important roles in neurogenesis, sensory pathways, and homeostatic regulation. Here, we found that the interleukin 4 receptor {alpha} (IL-4R{alpha}) gene is up-regulated by p73 but not significantly by p53 in several human cancer cell lines. IL-4R{alpha}transcription is also activated in response to cisplatin, a DNA-damaging agent known to induce p73. By using small interference RNA designed to target p73, we demonstrated that silencing endogenous p73 abrogates the induction of the IL-4R{alpha} gene after cisplatin treatment. Furthermore, we identified a p73-binding site in the first intron of the IL-4R{alpha} gene that can directly interact with the p73 protein in vivo. This p73-binding site consists of eight copies of a 10-bp consensus p53-binding motif and is a functional response element that is relatively specific for p73 among the p53 family. p73ß promoted localized nucleosomal acetylation through recruitment of coactivator p300, indicating that p73 regulates transcription of IL-4R{alpha} through the unique p73-binding site. We also found that p73ß-transfected tumor cells are sensitive to IL-4-mediated apoptosis. Our data suggest that IL-4R{alpha} could mediate, in part, certain immune responses and p73-dependent cell death.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Sasaki, H. Negishi, R. Koyama, N. Anbo, K. Ohori, M. Idogawa, H. Mita, M. Toyota, K. Imai, Y. Shinomura, et al.
p53 Family Members Regulate the Expression of the Apolipoprotein D Gene
J. Biol. Chem., January 9, 2009; 284(2): 872 - 883.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Sasaki, H. Negishi, M. Idogawa, H. Suzuki, H. Mita, M. Toyota, Y. Shinomura, K. Imai, and T. Tokino
Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models
Mol. Cancer Ther., April 1, 2008; 7(4): 779 - 787.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Y. Sasaki, Y. Oshima, R. Koyama, R. Maruyama, H. Akashi, H. Mita, M. Toyota, Y. Shinomura, K. Imai, and T. Tokino
Identification of Flotillin-2, a Major Protein on Lipid Rafts, as a Novel Target of p53 Family Members
Mol. Cancer Res., March 1, 2008; 6(3): 395 - 406.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Aoudjehane, P. Podevin, O. Scatton, P. Jaffray, I. Dusanter-Fourt, G. Feldmann, P.-P. Massault, L. Grira, A. Bringuier, B. Dousset, et al.
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway
FASEB J, May 1, 2007; 21(7): 1433 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Maruyama, F. Aoki, M. Toyota, Y. Sasaki, H. Akashi, H. Mita, H. Suzuki, K. Akino, M. Ohe-Toyota, Y. Maruyama, et al.
Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation.
Cancer Res., May 1, 2006; 66(9): 4574 - 4583.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Osada, H. L. Park, Y. Nagakawa, K. Yamashita, A. Fomenkov, M. S. Kim, G. Wu, S. Nomoto, B. Trink, and D. Sidransky
Differential Recognition of Response Elements Determines Target Gene Specificity for p53 and p63
Mol. Cell. Biol., July 15, 2005; 25(14): 6077 - 6089.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Howell, C. Borchers, and S. L. Milgram
Heterogeneous Nuclear Ribonuclear Protein U Associates with YAP and Regulates Its Co-activation of Bax Transcription
J. Biol. Chem., June 18, 2004; 279(25): 26300 - 26306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.